We are live on ! Find out more
HCA

Horan Capital Advisors Portfolio holdings

AUM $297M
1-Year Est. Return 9.75%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+9.75%
3 Year Est. Return
+26.64%
5 Year Est. Return
+133.08%
10 Year Est. Return
+209.33%
AUM
$113M
AUM Growth
+$3.6M
Cap. Flow
+$3.19M
Cap. Flow %
2.82%
Top 10 Hldgs %
36.26%
Holding
70
New
5
Increased
40
Reduced
11
Closed
13
Avg Time Held
3.9 quarters
Top 10 Avg Time Held
2.8 quarters
Top 20 Avg Time Held
2.7 quarters

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$2.12M
2
CMCSA icon
Comcast
CMCSA
+$1.92M
3
VZ icon
Verizon
VZ
+$1.25M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$818K
5
MU icon
Micron Technology
MU
+$761K

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$1.61M
2
O icon
Realty Income
O
+$1.19M
3
PFE icon
Pfizer
PFE
+$991K
4
MON
Monsanto Co
MON
+$989K
5
VOD icon
Vodafone
VOD
+$908K

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.45%
2 Technology 14.24%
3 Healthcare 13.83%
4 Industrials 9.81%
5 Financials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CVX icon
51
Chevron
CVX
$405B
$337K 0.3%
2,827
+275
+11% +$35.1K
2013 Q2
5 quarters
WSBC icon
52
WesBanco
WSBC
$3.62B
$336K 0.3%
11,000
– –
2013 Q2
5 quarters
GE icon
53
GE Aerospace
GE
$318B
$271K 0.24%
2,204
+61
+3% +$7.6K
2013 Q4
3 quarters
MO icon
54
Altria Group
MO
$113B
$230K 0.2%
+5,000
New +$214K
2014 Q3
0 quarters
CAT icon
55
Caterpillar
CAT
$390B
$229K 0.2%
2,315
-300
-11% -$31.8K
2013 Q3
4 quarters
NSC icon
56
Norfolk Southern
NSC
$71B
$220K 0.19%
+1,975
New +$209K
2014 Q3
0 quarters
CINF icon
57
Cincinnati Financial
CINF
$24.9B
$214K 0.19%
+4,551
New +$217K
2014 Q3
0 quarters
AMGN icon
58
Amgen
AMGN
$218B
– –
-1,705
Closed -$202K –
BIIB icon
59
Biogen
BIIB
$33B
– –
-2,211
Closed -$697K –
BMY icon
60
Bristol-Myers Squibb
BMY
$120B
– –
-7,211
Closed -$350K –
FITB
61
Fifth Third Bancorp
FITB
$46.1B
– –
-28,413
Closed -$607K –
LMT icon
62
Lockheed Martin
LMT
$117B
– –
-1,456
Closed -$234K –
MRK icon
63
Merck
MRK
$344B
– –
-5,133
Closed -$283K –
ORCL icon
64
Oracle
ORCL
$432B
– –
-12,574
Closed -$510K –
PFE icon
65
Pfizer
PFE
$156B
– –
-35,195
Closed -$991K –
VOD icon
66
Vodafone
VOD
$38.9B
– –
-27,180
Closed -$908K –
VWO icon
67
Vanguard FTSE Emerging Markets ETF
VWO
$128B
– –
-16,088
Closed -$694K –
TUP
68
DELISTED
Tupperware Brands Corporation
TUP
– –
-4,200
Closed -$352K –
APC
69
DELISTED
Anadarko Petroleum
APC
– –
-1,868
Closed -$204K –
MON
70
DELISTED
Monsanto Co
MON
– –
-7,925
Closed -$989K –
1 2
3

Similar funds

WGCA
Wolf Group Capital Advisors Fairfax, Virginia $298M AUM 8.97% 1-Year Est. Return
RAM
Roanoke Asset Management Jersey City, New Jersey $292M AUM 6.35% 1-Year Est. Return
WFA
Wade Financial Advisory Campbell, California $292M AUM 5.04% 1-Year Est. Return
PPWP
Proquility Private Wealth Partners Las Vegas, Nevada $324M AUM 8.88% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return
BCM
BluePointe Capital Management Menlo Park, California $262M AUM 9.24% 1-Year Est. Return
IAM
Impact Asset Management Vienna $255M AUM
UFA
US Financial Advisors Braintree, Massachusetts $338M AUM 4.11% 1-Year Est. Return

Horan Capital Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Horan Capital Advisors held 70 positions worth $113M, up 3.3% from $109M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Horan Capital Advisors's Q3 2014 filing shows 5 new, 40 increased, 11 reduced and 13 closed positions. Its largest new stake was DuPont de Nemours: 15,890 shares worth $2.11M. The largest sale was US Bancorp, an estimated $1.61M.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Horan Capital Advisors's largest Q3 2014 buy was DuPont de Nemours: 15,890 shares worth $2.11M.
  • Horan Capital Advisors added most to Verizon in Q3 2014, an estimated $1.25M increase.
  • Horan Capital Advisors's biggest Q3 2014 reduction was US Bancorp, cutting an estimated $1.61M.
  • Horan Capital Advisors fully exited Pfizer in Q3 2014, selling an estimated $991K.
  • Horan Capital Advisors's ten largest holdings make up 36% of its $113M portfolio in Q3 2014.
  • Horan Capital Advisors opened 5 new positions and closed 13 in Q3 2014.
  • Horan Capital Advisors's portfolio value rose 3.3% quarter-over-quarter to $113M.

Based on Horan Capital Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.